Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The benefits of yoga for rheumatoid arthritis: results of a preliminary, structured 8-week program.

Badsha H, Chhabra V, Leibman C, Mofti A, Kong KO.

Rheumatol Int. 2009 Oct;29(12):1417-21. doi: 10.1007/s00296-009-0871-1. Epub 2009 Jan 31.

PMID:
19184028
2.

Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.

Revicki D, Ganguli A, Kimel M, Roy S, Chen N, Safikhani S, Cifaldi M.

Value Health. 2015 Dec;18(8):1008-15. doi: 10.1016/j.jval.2015.09.2941. Epub 2015 Nov 17.

3.

Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.

Miwa Y, Takahashi R, Ikari Y, Maeoka A, Nishimi S, Oguro N, Hayashi T, Hatano M, Isojima S, Yanai R, Kasama T, Toyoshima Y, Inagaki K, Sanada K.

Intern Med. 2017;56(8):903-906. doi: 10.2169/internalmedicine.56.8039. Epub 2017 Apr 15.

4.

Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.

Strand V, Rentz AM, Cifaldi MA, Chen N, Roy S, Revicki D.

J Rheumatol. 2012 Jan;39(1):63-72. doi: 10.3899/jrheum.101161. Epub 2011 Nov 1.

5.

[The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study].

Abalos Medina GM, Ruiz Villaverde G, Sánchez Cano D, Ruiz Villaverde R, Ramírez Rodrigo J, Raya Álvarez E, Villaverde Gutiérrez C.

Reumatol Clin. 2011 May-Jun;7(3):167-71. doi: 10.1016/j.reuma.2010.06.004. Epub 2011 Jan 22. Spanish.

6.

Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.

Martin WJ, Shim M, Paulus HE, Chaudhari S, Feng J, Elashoff D, Hahn TJ, Ranganath VK; RADIUS Investigators.

J Clin Rheumatol. 2014 Sep;20(6):301-5. doi: 10.1097/RHU.0000000000000152.

7.

Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.

Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, Singh G, Yamanaka H.

Ann Rheum Dis. 2008 Aug;67(8):1153-8. Epub 2007 Oct 30.

PMID:
17971459
8.

A randomized controlled trial examining Iyengar yoga for young adults with rheumatoid arthritis: a study protocol.

Evans S, Cousins L, Tsao JC, Subramanian S, Sternlieb B, Zeltzer LK.

Trials. 2011 Jan 21;12:19. doi: 10.1186/1745-6215-12-19.

9.

Iyengar yoga for young adults with rheumatoid arthritis: results from a mixed-methods pilot study.

Evans S, Moieni M, Taub R, Subramanian SK, Tsao JC, Sternlieb B, Zeltzer LK.

J Pain Symptom Manage. 2010 May;39(5):904-13. doi: 10.1016/j.jpainsymman.2009.09.018.

PMID:
20471550
10.

Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.

Eberhardt K, Sandqvist G, Geborek P.

Scand J Rheumatol. 2008 Mar-Apr;37(2):109-12. doi: 10.1080/03009740701747129.

PMID:
18415767
11.

Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds.

Strand V, Kosinski M, Gnanasakthy A, Mallya U, Mpofu S.

Health Qual Life Outcomes. 2014 Mar 5;12:31. doi: 10.1186/1477-7525-12-31.

12.

Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.

Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Ma M, Walker D, Heslin M, Patel A, Kingsley G.

Health Technol Assess. 2014 Oct;18(66):i-xxiv, 1-164. doi: 10.3310/hta18660.

13.

Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA).

Osterhaus JT, Purcaru O, Richard L.

Arthritis Res Ther. 2009;11(3):R73. doi: 10.1186/ar2702. Epub 2009 May 20.

14.

The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial.

Bingham CO 3rd, Weinblatt M, Han C, Gathany TA, Kim L, Lo KH, Baker D, Mendelsohn A, Westhovens R.

J Rheumatol. 2014 Jun;41(6):1067-76. doi: 10.3899/jrheum.130864. Epub 2014 May 1.

PMID:
24786931
15.

Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.

Boubouchairopoulou N, Flouri I, Drosos AA, Boki K, Settas L, Zisopoulos D, Skopouli FN, Papadopoulos I, Iliopoulos A, Kyriopoulos J, Boumpas DT, Athanasakis K, Sidiropoulos P.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):999-1005. Epub 2016 Oct 7.

PMID:
27749220
16.

Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence.

Stockl KM, Shin JS, Lew HC, Zakharyan A, Harada AS, Solow BK, Curtis BS.

J Manag Care Pharm. 2010 Oct;16(8):593-604.

17.

Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.

Nair SC, Bijlsma JW, van der Werf JH, van der Veen MJ, Linn-Rasker SP, Vreugdenhil S, Lafeber FP, Welsing PM.

J Rheumatol. 2013 Sep;40(9):1505-12. doi: 10.3899/jrheum.121346. Epub 2013 Jul 1.

PMID:
23818710
18.

Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.

Sanmartí R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J.

Rheumatology (Oxford). 2005 Sep;44(9):1140-4. Epub 2005 May 31.

PMID:
15927997
19.

EFFECT OF THERAPY WITH ANTI-TNF α DRUGS AND DMARD ON DISEASE ACTIVITY AND HEALTH RELATED QUALITY OF LIFE AMONG WOMEN WITH RHEUMATOID ARTHRITIS.

Kopciuch D, Paczkowska A, Leszczynsk P, Michalak M, Nowakowskai E.

Acta Pol Pharm. 2016 Mar-Apr;73(2):547-54.

PMID:
27180448
20.

Supplemental Content

Support Center